BeStock  
Stocks › Medical Devices › INSP

Inspire Medical Systems INSP

US equityMarket cap rank #2833Medical DevicesBrain-Computer Interface
$55.10 −$1.18 (-2.10%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $55.10 0.00%
Open$56.24
Prev close$56.28
Day range$54.90 – $56.93
Volume552.3K
Market cap$1.60B
P/E (TTM)16.4
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$206.70M-7.9% YoY
Operating profit-$28.72M-397.8% YoY
Net profit-$24.39M-345.6% YoY
Diluted EPS-$0.84-347.1% YoY
Free cash flow$38.88M-33.1% YoY
Operating cash flow$46.43M

Revenue, last 8 quarters

$239.7MDec '24$201.3MMar '25$217.1MJun '25$224.5MSep '25$269.1MDec '25$204.6MMar '26$200.6MJun '26$206.7MSep '26

Net profit, last 8 quarters

$35.2MDec '24$3.0MMar '25$-3.6MJun '25$9.9MSep '25$136.1MDec '25$-11.3MMar '26$314.0KJun '26$-24.4MSep '26

Diluted EPS by quarter

1.15Dec '240.10Mar '25-0.12Jun '250.34Sep '254.66Dec '25-0.39Mar '260.01Jun '26-0.84Sep '26

Free cash flow by quarter

$62.2MDec '24$-15.1MMar '25$-6.3MJun '25$58.1MSep '25$41.8MDec '25$3.1MMar '26$14.1MJun '26$38.9MSep '26

Annual revenue

$115.4MFY20$233.4MFY21$407.9MFY22$624.8MFY23$802.8MFY24$912.0MFY25

Profitability & balance sheet

Gross margin86.2%
Operating margin1.8%
Net margin11.4%
Return on equity13.5%
Return on assets11.4%
Return on invested capital11.8%
Current ratio6.45
Liabilities / assets13.2%
Cash & investments$327.97M
Total debt$28.61M
Net cash (debt)$299.36M
Free cash flow / sales11.1%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $206.70M $200.58M $204.58M $911.98M $269.08M
Total Operating Revenue $206.70M $200.58M $204.58M $911.98M $269.08M
Cost of Revenue $28.84M $29.12M $27.67M $133.23M $36.07M
Gross Profit $177.86M $171.46M $176.91M $778.76M $233.01M
Operating Expense $206.57M $171.97M $178.03M $727.80M $186.90M
Selling and Admin Expenses $184.40M $147.28M $152.20M $624.64M $161.95M
Research & Development $22.18M $24.70M $25.83M $103.17M $24.94M
Operating Profit -$28.72M -$514,000.00 -$1.12M $50.95M $46.11M
Net Non-Operating Interest Income (Expense) $3.90M $3.74M $3.74M $17.40M $3.88M
Non-Operating Interest Income $3.90M $3.74M $3.74M $17.54M $4.02M
Other Income (Expense) -$191,000.00 -$110,000.00 -$226,000.00 -$2.66M $330,000.00
Other Non-Operating Income (Expenses) -$191,000.00 -$110,000.00 -$226,000.00 -$2.66M $330,000.00
Pretax Profit -$25.01M $3.12M $2.40M $65.70M $50.32M
Tax -$616,000.00 $2.80M $13.69M -$79.73M -$85.77M
Net Profit -$24.39M $314,000.00 -$11.29M $145.42M $136.09M
Profit from Continuing Operations -$24.39M $314,000.00 -$11.29M $145.42M $136.09M
Net Income to Parent Company -$24.39M $314,000.00 -$11.29M $145.42M $136.09M
Net Income to Common Stockholders -$24.39M $314,000.00 -$11.29M $145.42M $136.09M
Basic EPS -$0.84 $0.01 -$0.39 $4.95 $4.70
Diluted EPS -$0.84 $0.01 -$0.39 $4.89 $4.66
Non-Operating Interest Expense – – – $137,000.00 $122,000.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $953.03M $925.99M $911.38M $907.32M $907.32M
Total Current Assets $627.63M $608.67M $566.82M $583.65M $583.65M
Cash and Cash Equivalents & Short-Term Investments $327.97M $320.68M $283.83M $308.27M $308.27M
-Cash and Cash Equivalents $190.80M $127.76M $98.93M $104.81M $104.81M
-Short Term Investments $137.17M $192.92M $184.90M $203.46M $203.46M
Receivables $104.71M $103.34M $105.09M $119.69M $119.69M
-Accounts Receivable $104.71M $103.34M $105.09M $119.69M $119.69M
Inventory $178.96M $170.45M $166.24M $145.29M $145.29M
Other Current Assets $15.99M $14.20M $11.66M $10.40M $10.40M
Total Non-Current Assets $325.41M $317.32M $344.56M $323.67M $323.67M
Net PPE $107.76M $126.93M $123.76M $121.40M $121.40M
-Gross PPE $107.76M $126.93M $123.76M $147.05M $147.05M
Investments and Advances $125.13M $94.48M $115.88M $96.33M $96.33M
-Available for Sale Securities $125.13M $94.48M $115.88M $96.33M $96.33M
Non-Current Deferred Assets $74.20M $77.58M $87.67M $88.67M $88.67M
Other Non-Current Assets $18.33M $18.33M $17.25M $17.26M $17.26M
Total Liabilities $126.08M $100.41M $119.04M $126.16M $126.16M
Total Current Liabilities $97.34M $71.18M $89.42M $96.06M $96.06M
Payables $38.07M $27.10M $41.85M $39.02M $39.02M
-Accounts Payable $38.07M $27.10M $41.85M $36.57M $36.57M
Current Accrued Expenses $59.27M $44.08M $47.57M $54.88M $54.88M
Total Non-Current Liabilities $28.75M $29.23M $29.62M $30.10M $30.10M
Long Term Debt and Capital Lease Obligation $28.61M $29.09M $29.55M $30.00M $30.00M
-Long Term Capital Lease Obligation $28.61M $29.09M $29.55M $30.00M $30.00M
Other Non-Current Liabilities $135,000.00 $136,000.00 $66,000.00 $104,000.00 $104,000.00
Total Equity $826.95M $825.58M $792.34M $781.16M $781.16M
Stockholders' Equity $826.95M $825.58M $792.34M $781.16M $781.16M
Capital Stock $29,000.00 $29,000.00 $29,000.00 $29,000.00 $29,000.00
-Common Stock $29,000.00 $29,000.00 $29,000.00 $29,000.00 $29,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.01B $983.67M $950.45M $927.16M $927.16M
Retained Earnings -$181.87M -$157.47M -$157.79M -$146.49M -$146.49M
Gains/Losses Not Affecting Retained Earnings -$1.45M -$645,000.00 -$352,000.00 $464,000.00 $464,000.00
-Accumulated Depreciation – – – -$25.65M -$25.65M
-Total Tax Payable – – – $2.45M $2.45M
Short-Term Debt and Capital Lease Obligation – – – $2.16M $2.16M
-Current Capital Lease Obligation – – – $2.16M $2.16M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $46.43M $23.23M $12.85M $116.98M $52.47M
Net cash flow from continuing operations $46.43M $23.23M $12.85M $116.98M $52.47M
Net Income from Continuing Operations -$24.39M $314,000.00 -$11.29M $145.42M $136.09M
Depreciation & Depletion & Amortization $5.14M $4.60M $5.11M $13.96M $3.82M
Deferred Tax $3.39M $10.15M $1.01M -$88.75M -$88.75M
Other Non-Cash Items $349,000.00 $193,000.00 $548,000.00 $2.11M $325,000.00
Change in Working Capital $14.34M -$22.83M -$13.11M -$87.38M -$26.85M
-Change in Receivables -$1.11M $1.93M $14.29M -$26.23M -$11.63M
-Change in Inventory -$8.51M -$4.22M -$20.94M -$65.18M -$3.52M
-Change in Prepaid Assets -$1.79M -$2.81M -$1.26M $1.65M $3.76M
-Change in Payables and Accrued Expense $25.75M -$17.74M -$5.19M $2.38M -$15.47M
Net cash flow from investing $17.05M $3.55M -$11.25M $21.45M -$11.92M
Net Cash Flow from Continuing Investing Activities $17.05M $3.55M -$11.25M $21.45M -$11.92M
Net Investment Purchase and Sale $24.59M $12.71M -$1.52M $59.95M -$1.26M
Financing Cash Flow -$436,000.00 $1.91M -$7.48M -$183.45M -$48.31M
Net Cash Flow from Continuing Financing Activities -$436,000.00 $1.91M -$7.48M -$183.45M -$48.31M
Net Common Stock Issuance $0.00 $0.00 $0.00 -$175.02M -$50.01M
Proceeds from Stock Option Exercised $313,000.00 $2.60M $109,000.00 $14.61M $2.40M
Net Other Financing Charges -$749,000.00 -$685,000.00 -$7.59M -$23.04M -$694,000.00
Ending Cash Balance $190.80M $127.76M $98.93M $104.81M $104.81M
Net Change in Cash $63.04M $28.69M -$5.88M -$45.03M -$7.76M
Beginning Cash Balance $127.76M $98.93M $104.81M $150.15M $112.85M
Effect of Exchange Rate Changes $4,000.00 $142,000.00 $1,000.00 -$310,000.00 -$275,000.00
Free Cash Flow $38.88M $14.07M $3.12M $78.48M $41.81M
Capital Expenditure – -$9.16M -$9.73M – –
Net PPE Purchase and Sale – – – -$38.50M -$10.66M

Discussion

No comments yet — be the first to weigh in on INSP.

Sign in to join the discussion.

Scroll to Top